Nov-08-24 08:00AM
07:00AM
Nov-04-24 07:00AM
Oct-01-24 05:09PM
04:03PM
(Investor's Business Daily)
02:39PM
Loading…
02:39PM
11:40AM
09:52AM
08:00AM
Sep-30-24 04:01PM
Sep-18-24 09:33AM
Sep-10-24 04:05PM
Aug-22-24 12:00PM
Aug-14-24 08:00AM
07:00AM
09:35AM
Loading…
Jul-12-24 09:35AM
May-29-24 07:00AM
May-10-24 02:38PM
May-09-24 07:38AM
May-08-24 10:55PM
05:55PM
04:10PM
May-07-24 07:00AM
May-03-24 10:00AM
Apr-30-24 12:00PM
Apr-17-24 08:30AM
Apr-10-24 07:00AM
Mar-07-24 10:52PM
05:45PM
04:10PM
09:55AM
Loading…
Mar-01-24 09:55AM
Feb-14-24 09:55AM
Feb-01-24 07:00AM
Jan-16-24 08:38AM
Jan-03-24 07:00AM
Dec-08-23 04:09AM
Dec-06-23 02:44AM
Dec-05-23 04:01PM
Dec-01-23 05:32AM
Nov-27-23 03:52AM
Nov-22-23 02:46AM
Nov-21-23 02:48AM
Nov-16-23 09:55AM
Nov-14-23 07:28PM
Nov-13-23 04:10PM
03:49AM
Nov-07-23 07:00AM
Oct-25-23 02:46AM
Oct-23-23 02:48AM
Oct-20-23 09:29AM
Oct-05-23 07:29AM
Oct-03-23 04:05PM
(GlobeNewswire) -7.06%
-10.66%
Sep-20-23 04:36AM
Sep-06-23 07:00AM
Aug-10-23 08:59PM
Aug-03-23 05:25PM
04:10PM
Jul-05-23 06:46AM
Jul-03-23 04:01PM
Jun-30-23 09:48AM
Jun-22-23 08:14PM
07:58AM
Jun-21-23 05:17PM
Jun-02-23 05:30PM
(GlobeNewswire) +5.92%
-22.13%
Jun-01-23 07:00AM
May-31-23 07:00AM
May-30-23 07:00AM
May-25-23 11:58AM
May-12-23 10:15AM
09:05AM
May-02-23 07:00AM
Apr-28-23 11:50AM
Apr-19-23 07:00AM
Apr-13-23 04:05PM
Apr-06-23 12:23PM
Apr-01-23 09:17AM
Mar-30-23 06:05PM
04:05PM
Mar-27-23 07:00AM
Feb-02-23 07:00AM
Jan-17-23 07:00AM
Jan-09-23 07:00AM
Jan-03-23 07:00AM
Dec-11-22 10:00AM
Dec-01-22 07:00AM
Nov-16-22 06:37AM
Nov-08-22 07:00AM
Nov-03-22 10:25AM
09:05AM
Nov-02-22 04:05PM
Oct-27-22 02:06PM
Sep-06-22 07:00AM
Aug-08-22 06:45PM
04:10PM
Jul-04-22 02:04PM
Jun-01-22 07:00AM
May-20-22 12:07PM
May-10-22 07:00AM
May-09-22 04:16PM
May-06-22 07:00AM
IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies. The firm's product pipeline includes IGM-2323, which is a CD20 x CD3 bispecific IgM antibody designed to treat patients with B cell Non-Hodgkin's lymphoma and other B cell malignancies, IGM-8444, which is an IgM antibody targeting Death Receptor 5 for the treatment of patients with solid and hematologic malignancies, and IGM-7354, which will target the delivery of IL-15 with the goal of inducing immune cell stimulation and proliferation. The company was founded in 2010 and is headquartered in Mountain View, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Weber Steven PRINCIPAL ACCOUNTING OFFICER Sep 13 '24 Sale 11.54 469 5,412 25,543 Sep 17 08:58 PM Takimoto Chris H CHIEF MEDICAL OFFICER Sep 13 '24 Sale 11.54 1,487 17,158 154,331 Sep 17 08:55 PM Tahir Misbah CHIEF FINANCIAL OFFICER Sep 13 '24 Sale 11.54 1,487 17,158 122,694 Sep 17 08:54 PM Schwarzer Fred CEO AND PRESIDENT Sep 13 '24 Sale 11.54 3,946 45,532 250,124 Sep 17 08:52 PM Keyt Bruce CHIEF SCIENTIFIC OFFICER Sep 13 '24 Sale 11.54 1,487 17,158 242,948 Sep 17 08:50 PM Harler Mary Beth Head, Research & Autoimmunity Sep 13 '24 Sale 11.54 1,487 17,158 163,740 Sep 17 08:44 PM Decker Lisa Lynn CHIEF BUSINESS OFFICER Sep 13 '24 Sale 11.54 925 10,673 79,104 Sep 17 08:42 PM Hambleton Julie Director Jul 25 '24 Option Exercise 1.39 15,132 21,033 17,132 Jul 29 05:45 PM Hambleton Julie Director Jul 25 '24 Sale 14.00 15,132 211,848 2,000 Jul 29 05:45 PM Weber Steven PRINCIPAL ACCOUNTING OFFICER Jun 14 '24 Sale 7.58 495 3,750 26,012 Jun 18 07:45 PM Takimoto Chris H CHIEF MEDICAL OFFICER Jun 14 '24 Sale 7.58 1,570 11,893 95,818 Jun 18 07:44 PM Tahir Misbah CHIEF FINANCIAL OFFICER Jun 14 '24 Sale 7.58 1,570 11,893 88,848 Jun 18 07:43 PM Schwarzer Fred CEO AND PRESIDENT Jun 14 '24 Sale 7.58 4,164 31,544 254,070 Jun 18 07:42 PM Keyt Bruce CHIEF SCIENTIFIC OFFICER Jun 14 '24 Sale 7.58 1,106 8,378 197,769 Jun 18 07:41 PM Harler Mary Beth Head, Research & Autoimmunity Jun 14 '24 Sale 7.58 1,570 11,893 85,227 Jun 18 07:40 PM Decker Lisa Lynn CHIEF BUSINESS OFFICER Jun 14 '24 Sale 7.58 977 7,401 60,029 Jun 18 07:38 PM BAKER BROS. ADVISORS LP Director Mar 26 '24 Buy 8.26 270,000 2,230,767 3,638,533 Mar 28 07:04 PM BAKER BROS. ADVISORS LP Director Mar 28 '24 Buy 9.62 97,473 937,632 3,753,480 Mar 28 07:04 PM BAKER BROS. ADVISORS LP Director Mar 27 '24 Buy 9.24 27,844 257,170 3,664,073 Mar 28 07:04 PM Weber Steven PRINCIPAL ACCOUNTING OFFICER Mar 13 '24 Sale 9.88 529 5,224 26,971 Mar 15 07:57 PM Weber Steven PRINCIPAL ACCOUNTING OFFICER Mar 14 '24 Sale 10.17 464 4,719 26,507 Mar 15 07:57 PM Takimoto Chris H CHIEF MEDICAL OFFICER Mar 13 '24 Sale 9.88 2,889 28,529 96,923 Mar 15 07:55 PM Takimoto Chris H CHIEF MEDICAL OFFICER Mar 14 '24 Sale 10.17 2,535 25,782 94,388 Mar 15 07:55 PM Tahir Misbah CHIEF FINANCIAL OFFICER Mar 13 '24 Sale 9.88 2,897 28,608 92,961 Mar 15 07:53 PM Tahir Misbah CHIEF FINANCIAL OFFICER Mar 14 '24 Sale 10.17 2,543 25,864 90,418 Mar 15 07:53 PM Schwarzer Fred CEO AND PRESIDENT Mar 13 '24 Sale 9.88 4,765 47,055 220,833 Mar 15 07:51 PM Schwarzer Fred CEO AND PRESIDENT Mar 14 '24 Sale 10.17 4,182 42,533 216,651 Mar 15 07:51 PM Keyt Bruce CHIEF SCIENTIFIC OFFICER Mar 13 '24 Sale 9.88 2,101 20,748 173,700 Mar 15 07:49 PM Keyt Bruce CHIEF SCIENTIFIC OFFICER Mar 14 '24 Sale 10.17 1,844 18,754 171,856 Mar 15 07:49 PM Decker Lisa Lynn CHIEF BUSINESS OFFICER Mar 13 '24 Sale 9.88 1,798 17,756 62,584 Mar 15 07:48 PM Decker Lisa Lynn CHIEF BUSINESS OFFICER Mar 14 '24 Sale 10.17 1,578 16,049 61,006 Mar 15 07:48 PM Keyt Bruce CHIEF SCIENTIFIC OFFICER Mar 01 '24 Option Exercise 0.93 3,026 2,814 4,039 Mar 05 07:34 PM Schwarzer Fred CEO and President Dec 13 '23 Sale 5.78 17,576 101,558 102,848 Dec 15 07:20 PM Keyt Bruce Chief Scientific Officer Dec 13 '23 Sale 5.78 7,574 43,764 129,551 Dec 15 07:19 PM Decker Lisa Lynn Chief Business Officer Dec 13 '23 Sale 5.78 4,369 25,245 35,632 Dec 15 07:18 PM BAKER BROS. ADVISORS LP Director Dec 15 '23 Buy 6.55 288,007 1,887,531 3,390,323 Dec 15 05:32 PM BAKER BROS. ADVISORS LP Director Dec 14 '23 Buy 6.50 157,370 1,023,157 3,123,585 Dec 15 05:32 PM BAKER BROS. ADVISORS LP Director Dec 13 '23 Buy 5.96 87,316 520,776 2,977,836 Dec 15 05:32 PM Takimoto Chris H Chief Medical Officer Nov 29 '23 Sale 6.21 1,180 7,331 53,562 Dec 01 07:03 PM Gauthier George Chief Commercial Officer Nov 29 '23 Sale 6.21 1,180 7,331 39,642 Dec 01 07:02 PM Decker Lisa Lynn Chief Business Officer Nov 29 '23 Sale 6.21 1,180 7,331 40,001 Dec 01 07:01 PM Tahir Misbah Chief Financial Officer Nov 27 '23 Sale 5.06 1,337 6,764 49,608 Nov 29 08:49 PM Schwarzer Fred CEO and President Nov 27 '23 Sale 5.06 1,337 6,764 120,424 Nov 29 08:48 PM Keyt Bruce Chief Scientific Officer Nov 27 '23 Sale 5.06 933 4,720 137,125 Nov 29 08:47 PM